Literature DB >> 17907050

Tissue microarrays in clinical urology--technical considerations.

Mario W Kramer1, Axel S Merseburger, Jorg Hennenlotter, Markus Kuczyk.   

Abstract

The tissue microarray (TMA) technique is a 'high-throughput' tool which enables a rapid and concurrent analysis of molecular targets in large numbers of specimens at the DNA, RNA and protein levels under standardized conditions. In addition, TMA is a cost- and time-efficient method. This review focuses on its technical side, outlining its advantages and weaknesses. It also gives an overview of some major studies of bladder and prostate cancer in which the TMA technique was used.

Entities:  

Mesh:

Year:  2007        PMID: 17907050     DOI: 10.1080/00365590701430737

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  10 in total

1.  Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?

Authors:  M Horstmann; L M Geiger; U Vogel; H Schmid; J Hennenlotter; U Kuehs; A S Merseburger; S Kruck; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2011-09-18       Impact factor: 4.226

2.  Maspin protein expression correlates with tumor progression in non-muscle invasive bladder cancer.

Authors:  Mario W Kramer; Sandra Waalkes; Jörg Hennenlotter; Jürgen Serth; Arnulf Stenzl; Markus A Kuczyk; Axel S Merseburger
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

3.  Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival.

Authors:  Axel S Merseburger; Mario W Kramer; Jörg Hennenlotter; Jürgen Serth; Stephan Kruck; Alfredo Gracia; Arnulf Stenzl; Markus A Kuczyk
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

4.  HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.

Authors:  Mario W Kramer; Roozbeh Golshani; Axel S Merseburger; Judith Knapp; Alfredo Garcia; Joerg Hennenlotter; Robert C Duncan; Mark S Soloway; Merce Jorda; Marcus A Kuczyk; Arnulf Stenzl; Vinata B Lokeshwar
Journal:  Eur Urol       Date:  2009-03-31       Impact factor: 20.096

5.  CSTP1, a novel protein phosphatase, blocks cell cycle, promotes cell apoptosis, and suppresses tumor growth of bladder cancer by directly dephosphorylating Akt at Ser473 site.

Authors:  De-Xiang Zhuo; Xiao-Wei Zhang; Bo Jin; Zheng Zhang; Bu-Shan Xie; Cheng-Lin Wu; Kan Gong; Ze-Bin Mao
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

6.  Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study.

Authors:  Isidro Machado; Francisco Giner; Empar Mayordomo; Carmen Carda; Samuel Navarro; Antonio Llombart-Bosch
Journal:  Diagn Pathol       Date:  2008-07-15       Impact factor: 2.644

7.  Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines.

Authors:  Rosa Noguera; Isidro Machado; Marta Piqueras; Jose Antonio Lopez-Guerrero; Samuel Navarro; Empar Mayordomo; Antonio Pellin; Antonio Llombart-Bosch
Journal:  Diagn Pathol       Date:  2008-07-15       Impact factor: 2.644

8.  Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique.

Authors:  Tian Tang; Duan-Lian Zhang
Journal:  Exp Ther Med       Date:  2015-02-12       Impact factor: 2.447

9.  Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study.

Authors:  Hisashi Oshiro; Bogdan A Czerniak; Kentaro Sakamaki; Koji Tsuta; Jolanta Bondaruk; Afsaneh Keyhani; Colin P Dinney; Takeshi Nagai; Ashish M Kamat
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).

Authors:  André P Nicklas; Mario W Kramer; Jürgen Serth; Jörg Hennenlotter; Marie C Hupe; Daniel U Reimer; Arnulf Stenzl; Axel S Merseburger; Markus A Kuczyk; Christoph-Alexander J von Klot
Journal:  Adv Ther       Date:  2018-09-19       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.